Press-release for stocks

Prices are updated after-hours

Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
VNDA | $4.56 -1.51% -1.31% 1.1M

| -9.79% | O: -5.84% H: 2.31% C: -2.73%
hetlioz pharmaceuticals

Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation
Published: 2024-04-22 (Crawled : 00:00) - prnewswire.com
VNDA | $4.56 -1.51% -1.31% 1.1M

| -9.79% | O: -5.84% H: 2.31% C: -2.73%
hetlioz pharmaceuticals

Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia
Published: 2024-03-06 (Crawled : 12:00) - prnewswire.com
VNDA | $4.56 -1.51% -1.31% 1.1M

| 10.14% | O: -1.21% H: 0.0% C: -4.4%
hetlioz fda update treatment pharmaceuticals

Vanda Pharmaceuticals Intends to Petition the U.S. Supreme Court in its HETLIOZ® ANDA Litigation
Published: 2023-10-20 (Crawled : 11:00) - prnewswire.com
VNDA | $4.56 -1.51% -1.31% 1.1M

| 5.8% | O: -0.23% H: 2.79% C: 0.93%
hetlioz pharmaceuticals

Tonix Pharmaceuticals Announces Acquisition of Preclinical Infectious Disease Portfolio from Healion Bio, Inc.
Published: 2023-02-02 (Crawled : 13:20) - biospace.com/
TNXP | $0.16 2.04% 1.2% 940K

| -97.81% | O: 0.85% H: 5.08% C: 0.0%
acquisition pharmaceuticals disease preclinical

Vanda Pharmaceuticals Responds to Ruling in HETLIOZ® ANDA Litigation
Published: 2022-12-13 (Crawled : 01:00) - biospace.com/
VNDA | $4.56 -1.51% -1.31% 1.1M

| -57.74% | O: 1.85% H: 0.18% C: -32.39%
hetlioz pharmaceuticals

VANDA PHARMACEUTICALS ANNOUNCES NOTICE OF OPPORTUNITY FOR AN FDA HEARING ON THE sNDA FOR HETLIOZ® IN JET LAG DISORDER
Published: 2022-09-07 (Crawled : 23:00) - prnewswire.com
VNDA | $4.56 -1.51% -1.31% 1.1M

| -55.6% | O: 0.0% H: 1.51% C: -0.68%
hetlioz fda

Vanda Pharmaceuticals Settles HETLIOZ® Patent Litigation with MSN
Published: 2022-01-14 (Crawled : 14:00) - prnewswire.com
VNDA | $4.56 -1.51% -1.31% 1.1M